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Despite surgical proficiency and innovation driving low mortality rates in cardiac surgery,
the disease severity, comorbidity rate, and operative procedural difficulty have increased.
Today’s cardiac surgery patient is older, has a “sicker” heart and often presents with
multiple comorbidities; a scenario that was relatively rare 20 years ago. The global
challenge has been to find new ways to make surgery safer for the patient and
more predictable for the surgeon. A confounding factor that may influence clinical
outcome is high K+ cardioplegia. For over 40 years, potassium depolarization has been
linked to transmembrane ionic imbalances, arrhythmias and conduction disturbances,
vasoconstriction, coronary spasm, contractile stunning, and low output syndrome. Other
than inducing rapid electrochemical arrest, high K+ cardioplegia offers little or no inherent
protection to adult or pediatric patients. This review provides a brief history of high K+
cardioplegia, five areas of increasing concern with prolonged membrane K+ depolarization,
and the basic science and clinical data underpinning a new normokalemic, “polarizing”
cardioplegia comprising adenosine and lidocaine (AL) with magnesium (Mg2+) (ALM™).
We argue that improved cardioprotection, better outcomes, faster recoveries and lower
healthcare costs are achievable and, despite the early predictions from the stent industry
and cardiology, the “cath lab” may not be the place where the new wave of high-risk
morbid patients are best served.
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INTRODUCTION
IN-HOSPITAL MORTALITY RATES: ONLY THE TIP OF THE ICEBERG
“Declare the past, diagnose the present, foretell the future; practice
these acts. As to diseases, make a habit of two things—to help, or
at least to do no harm.”
Attributed to Hippocrates (Epidemics, Bk.1, Sect. XI) (Markel,
2004)
Coronary artery disease is responsible for approximately one-
third of the world’s population deaths over 35 years of age
(Mangiacapra et al., 2011). Globally there are over 800,000 coro-
nary artery bypass graft (CABG) surgery or valvular operations
each year, with around 1000 operations each day in the US
(Goldman et al., 2004; Thom et al., 2006; Dobson, 2010). In-
hospital/30-day mortality rates are around 1% for CABG, 5–6%
for valve, and 7% for combined CABG and valve surgery (Nesher
et al., 2008; Hannan et al., 2013) (Figure 1). These mortality
rates are not equivalent across hospitals (Goodney et al., 2003),
age (Vicchio et al., 2012), gender (Edwards et al., 2005), ethnic-
ity (Becker and Rahimi, 2006; Song et al., 2008) or countries
(Menasché, 2000). Octogenarians have a 3-fold increased risk of
death (∼7.5%) compared with younger adults (Speziale et al.,
2011), and 90 year old, non-elective, patients have a mortality
ranging between 7 and 18% with a five year survival of 51%
(Speziale et al., 2010) (Milano et al., 1993). Adult females have up
to 1.6 times higher in-hospital mortality rates and higher mor-
bidity than their male counterparts (Edwards et al., 1998, 2005;
Vaccarino et al., 2002; Koch et al., 2003; Azakie and Russell, 2004).
The increased risks in woman are believed to involve greater
perioperative susceptibility to ischemia-reperfusion (IR) injury,
different myocyte-endothelial physiology, different hormonal sta-
tus, higher incidence of diabetes, hypertension and renal disease,
and the effect of age and ethnicity, with worse outcomes among
Afro-Americans (Edwards et al., 2005; Seifert et al., 2007; Martin
et al., 2012).
Pediatric patients also have a unique set of surgical and post-
operative challenges. Complex congenital corrective operations
have an in-hospital mortality rate of ∼5.0% and, as in adults, the
female gender appears to be an independent risk factor for higher
mortality and adverse events (1.3 times higher in-hospital mor-
tality) (Welke et al., 2006; Seifert et al., 2007). In high-risk, low
weight, pediatric patients (weighing < 2–2.5 kg) hypoplastic left
heart syndrome has an in-hospital mortality of 20–45% (Curzon
et al., 2008) (Figure 1).
POST-OPERATIVE MORBIDITY: THE VAST AREA BENEATH THE
SURFACE
Despite surgical proficiency and medical innovation driving
low mortality rates, the disease severity, operative procedural
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FIGURE 1 | Schematic representation of mortality and morbidity in
cardiac surgery. Mortality and morbidity have many interacting and
confounding factors with ischemia-reperfusion injury playing a
significant role in the underlying etiologies. Improving early
post-operative morbidity is an unmet need in cardiac surgery (see
text for Discussion).
difficulty, and comorbidity rate have all increased in recent years
(Figure 1). About 10% of CABG surgery patients will have sig-
nificant left ventricular dysfunction lasting several hours, days,
or weeks (Weisel, 1993; Mangano, 1995; Spinale, 1999). Twenty
five to 40% of patients will have post-operative atrial fibrillation
(Aranki et al., 1996; Mathew et al., 2004), and in those patients
undergoing combined CABG and valvular surgery the incidence
may increase to 69% (Scherr et al., 2006). In the USA alone,
atrial fibrillation costs healthcare providers over 1.5 billion dol-
lars per year (Steinberg, 2004), and this cost likely doubles on
a global scale. In addition, depending upon the type of surgery,
4–40% of patients will have some form of renal dysfunction
(Lagercrantz et al., 2010; Maganti et al., 2010; Shaw, 2012), and
10–40% of adult patients will experience transient cognitive dys-
function or delirium, which can last for up to 5 years (Newman
et al., 2001; Rudolph et al., 2009), and 2–13% patients will have a
stroke (Kellermann and Jungwirth, 2010). Perioperative bleeding
is another major complication of cardiac surgery and excessive
bleeding occurs around 20% of patients, and 5–7% will lose in
excess of 2 L within the first 24 h postoperatively (Raja, 2005;
Yavari and Becker, 2009). It has been estimated that about 50%
of blood loss is due to identifiable surgical bleeding, and the other
50% is due to a complex hypocoagulopathy associated with surgi-
cal trauma and cardiopulmonary bypass (Raja, 2005; Yavari and
Becker, 2009).
Among the very elderly, over 40% will experience signifi-
cant post-operative complications requiring extended ICU stays
often involving many weeks (Speziale et al., 2010). Similarly,
in pediatric patients undergoing complex congenital corrective
operations, many will have acute post-operative complications
such as tissue edema with postoperative weight gain (Golab
et al., 2011), systemic coagulation disorders (Hayash et al., 2011),
surgical complications and low output syndrome (up to 25%)
(Wernovsky et al., 1995; Hoffman et al., 2003), arrhythmias
(27–48%) (Delaney et al., 2006), renal dysfunction (up to 30%)
(Rosner and Okusa, 2006), and cerebral dysfunction and stroke
(5–10%) (Chen et al., 2009).
ROLE OF ISCHEMIA-REPERFUSION (IR) INJURY
Prior to the 1990s, there was considerable skepticism among
cardiologists and some cardiac surgeons regarding the clinical
authenticity of myocardial ischemia-reperfusion injury. However,
over the last two decades, IR injury has been recognized as a
significant contributor to mortality and morbidity in cardiac
surgery patients (Vaage and Valen, 1993; Vinten-Johansen and
Nakanishi, 1993; Anselmi et al., 2004; Beyersdorf, 2009), with
females being more susceptible than males (Abramov et al.,
2000; Butterworth et al., 2000; McCully et al., 2006; Doughtie
et al., 2010). Consequences of IR injury are exacerbated by
physiological responses to cardiopulmonary bypass and sur-
gical trauma caused by release of pro-inflammatory media-
tors. Hence, as opposed to IR injury found in percutaneous
coronary interventions, cardiac surgery represents a “three-hit”
model of potential injury to the heart: ischemia-reperfusion,
cardiopulmonary bypass and surgical trauma (Weman et al.,
2000). It may be more accurate to redefine reperfusion injury
as “postcardioplegic” injury (Vinten-Johansen and Nakanishi,
1993). Postcardioplegic injury is particularly prevalent during and
following the surgical trauma associated with adult and pediatric
cardiac surgery (Anselmi et al., 2004; Madhok et al., 2006; Welke
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et al., 2006; Seifert et al., 2007; Butler et al., 2009; Gessler et al.,
2009).
Post-cardioplegic injury is dependent on pre-operative and/or
intra-operative myocardial ischemia; without ischemia there is
no reperfusion injury. Injury is classified as reversible or irre-
versible. Reversible injury includes arrhythmias, edema, vascular
dysfunction, and contractile stunning expressed as low output
syndrome requiring inotropic or mechanical support to main-
tain acceptable hemodynamics (Vinten-Johansen and Nakanishi,
1993; Rudd and Dobson, 2011a). Irreversible reperfusion injury
includes necrosis and apoptosis (Anselmi et al., 2004, 2009).
Tissue edema and microvascular dysfunction can transition from
reversible to irreversible (i.e., no-reflow) in response to severe
or prolonged ischemia, and can contribute to ultimate necro-
sis of myocardium. Necrosis involves disruption or disintegra-
tion of the cell membrane, and the release of cell contents and
large proteins that are used as biomarkers indicative of mor-
phological injury, e.g., creatine kinase (CK, CK-MB) or cardiac
troponins (T or I subunits). Peri-operative cell death is sub-
stantiated by the release of these biomarkers into the plasma
(Costa et al., 2001; Lehrke et al., 2004). Numerous studies have
shown that these elevations in perioperative CK-MB or cTn
(within 24–48 h) are correlated with both short-term and long-
term risk of mortality (Klatte et al., 2001; Lehrke et al., 2004;
Domanski et al., 2011). This increase in biomarkers after surgery
has been ascribed in part to suboptimal intra-operative myocar-
dial protection. In contrast to necrosis, apoptosis, or programmed
cell death, is non-explosive, non-inflammatory cell death initi-
ated over a longer period of time than the more rapid onset of
necrosis.
Mechanisms of IR injury
Reperfusion injury is a process, and not an endpoint. The pro-
cess of Ischemia-reperfusion is associated with cell K+ efflux,
membrane depolarization, anaerobic lactate production and ATP
decline, intracellular H+, Na+, and Ca2+ loading, ionic imbal-
ances, cell swelling, free radical and oxidant production, mito-
chondrial pore opening and dysfunction, apoptosis and necrosis
(Piper et al., 2003, 2004; Cannon, 2005; Vinten-Johansen et al.,
2007b). Ischemia-reperfusion is also responsible for endothe-
lial activation leading to microvascular dysfunction and deteri-
oration of coronary flow reserve (Ferguson et al., 1996; Feng
et al., 2008), vasoconstriction and spasm (Ruel et al., 2004),
myocardial contractile dysfunction (Weisel, 1993; Allen, 2004),
reperfusion arrhythmias (Anselmi et al., 2004, 2009), activa-
tion of the inflammation cascade (cytokines, chemokines, com-
plement activation, neutrophil activation) (Levy and Tanaka,
2003; Merchant et al., 2008; Suleiman et al., 2008; Anselmi
et al., 2009) and coagulation imbalances (Raivio et al., 2009;
Yavari and Becker, 2009). Reperfusion following cardiac surgery
has shown to be associated with a significant thrombin gen-
eration followed by activation of protein C (Raivio et al.,
2009).
Potassium in cardioplegia and IR injury
Another factor that may exacerbate IR injury is high potassium
in cardioplegia. Each year, over four metric tons of depolarizing
potassium (K+) are perfused through the coronary arteries of
cardiac patients worldwide, and about two metric tons in USA
patients (Dobson, 2010). After presenting a brief history of K+
cardioplegia, we will discuss how prolonged K+-dependent cel-
lular depolarization can create a hostile, unnatural pro-ischemic
environment for the heart, which may contribute to damage and
post-operative morbidity in the cardiac surgery patient. Next,
we will discuss alternatives to high K+ cardioplegia including a
new polarizing cardioplegia and reanimation solution compris-
ing adenosine and lidocaine with Mg2+ (ALM™) (Dobson, 2004)
that may address the unmet needs of the new high-risk morbid
patient.
BRIEF HISTORY OF CARDIOPLEGIA: FROM RINGER TO CARDIAC
SURGERY
If too little potassium is present, the contractions become broader,
and there results in fusion of the beats. If too much potassium
is present . . . then the contraction of the ventricle is imperfect,
and by increasing the quantity of potassium salt the beat becomes
weaker and weaker till it stops.
Sidney Ringer (1883) FromMoore (Moore, 1911) pvii
The term cardioplegia (cardio, heart and plegia, paralysis) was first
introduced by Lam in 1957 (Lam et al., 1957), yet the method
of arrest has its roots in the early experiments of British phys-
iologist Sidney Ringer using the frog heart (Figure 2). In 1883
Ringer reported that potassium chloride was a powerful arrest-
ing agent (Ringer, 1883), a serendipitous discovery like many in
science and medicine (Dobson, 2005). Curiously, Ringer’s labo-
ratory had a malfunctioning water distiller, and his technician
prepared the heart solutions using tap water supplied by London’s
New River Water Company (Moore, 1911). The technician found
that hearts perfused with this tap water-based solution contracted
rhythmically and forcefully for a number of hours. After identify-
ing the anomalies between tap water that was high in calcium and
magnesium salts, and distilled water, Ringer had the experiments
repeated using distilled water, and the hearts quickly failed. To
maintain contraction it was necessary to add Ca2+ and other salts
to the crystalloid medium (Moore, 1911). By accident Ringer and
his team next discovered the importance of potassium in “still-
ing” the heart in diastole and calcium in “stimulating” the heart
in systole (see quote above).
A few decades later, Hering (1907) reported the association
between high serumpotassium and emergent “fibrillary” contrac-
tions, which led to cardiac arrest (Hering, 1953). In 1929, Hooker
extended these observations and showed in a fibrillating dog heart
that injecting 1ml of 2.5%KCl (336mM) into the coronary arter-
ies rapidly stopped the heart, and after washout the heart returned
to sinus rhythm (Hooker, 1929). Wiggers showed that an intra-
venous administration of calcium after KCl “cardioversion,” led
to a more stable recovery (Wiggers, 1950). In 1954, Montgomery
used a similar KCl approach in hypothermic human patients to
defibrillate hearts (Montgomery et al., 1954). However, it was not
until 1955 that Lam and colleagues in the US administered an
intraventricular injection of KCl (667mEq/L) to induce cardiac
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FIGURE 2 | A brief history of the development of potassium cardioplegia from basic science to cardiac surgery (See text for details).
arrest in hypothermic dogs (without bypass) (Lam et al., 1955).
Lam’s group subsequently abandoned the KCl method because
of refractory ventricular fibrillation (VF) and myocardial dam-
age during reperfusion and reanimation (Effler et al., 1956; Lam
et al., 1957; Schaff et al., 1978; Shiroishi, 1999) (Figure 2). Lam
also tried acetylcholine (10mg/kg body wt) to induce arrest and
while the heart would beat more forcefully during reanimation
than when KCl was used, the incidence of VF was higher (Weirich,
1962). Lam also noted that O2 consumption of the potassium-
arrested heart was lower than acetylcholine, implying it provided
a more complete arrest (Lam et al., 1955).
In 1955 Melrose and colleagues, after corresponding with
Lam’s group, conjectured that the likely source of arrhythmias
in Lam’s KCl model was from the chloride. The London team
performed the first cardioplegic arrest using a citrated form of
potassium in a canine model of cardiopulmonary bypass. The
“Melrose technic,” as it became known, used 2.0ml of 25% solu-
tion of tri-potassium citrate added to 18ml warm oxygenated
whole blood in a syringe (9:1 blood: potassium ratio), and inject-
ing directly into the aortic root of hypothermic dogs (25◦C)
(Melrose et al., 1955; Gerbode and Melrose, 1958). The heart
arrested in seconds and remained electrically quiescent for 30min
and returned good function in the healthy dog. Melrose’s group
were the first to propose that high potassium-citrate may afford
“elective reversible cardiac arrest” in human open-heart surgery
(Melrose et al., 1955). Three years later, Gerbode and Melrose
increasingly used potassium citrate to induce cardiac arrest in
humans (Gerbode and Melrose, 1958).
Despite the early clinical excitement (Effler et al., 1956), the
“Melrose technic” was abandoned in the late 1950s because it
predisposed the heart to what Lam and colleagues had always sus-
pected; refractory ventricular fibrillation, contractile dysfunction
and cell death (Allen and Lillehei, 1957; Helmsworth et al., 1959;
Nunn et al., 1959; Urschel et al., 1959; Wasserman et al., 1959;
Willman et al., 1959; Bjork and Fors, 1961; Tyers et al., 1975).
In 1962, Weirich wrote: “The use of the Melrose method of elec-
tive cardiac arrest induced by the single injection of a 2.5 percent
potassium citrate-oxygenated blood solution has been abandoned
by virtually all physicians who perform intracardiac operations.”
(Weirich, 1962). It is curious why little or no mention was made
by Melrose, Lam or early adopters about the possible mecha-
nism of potassium citrate or potassium chloride arrest, given
that K+-induced membrane depolarization was demonstrated by
Woodbury in 1950 using microelectrodes in single cardiac fibers
(Woodbury et al., 1950; Draper andWeidmann, 1951), by Burgen
in isolated atria (Burgen and Terroux, 1953) and by Weidmann
and colleagues in whole hearts (Niedergerke, 1956; Weidmann,
1956; Hoffman, 2002) (Figure 2). It appears that there were few
collaborations between those studying surgical cardioplegia and
researchers in the basic electrophysiological sciences. Importantly,
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while the “Melrose Technique” failed to reach efficacy, Melrose,
Lam and their colleagues contributed enormously to the early
history of cardiac surgery because they showed that surgical
cardioplegia, as a strategy of buying biological time, was feasible.
Over the next 15 years, high potassium cardioplegia was
placed on “clinical hold” by cardiac surgeons themselves as a
result of poor clinical outcomes (Nunn et al., 1959) (Figure 1).
Potassium-based solutions were eventually replaced by either: (1)
hypothermic or normothermic ischemic arrest induced by aortic
occlusion, (2) by intermittent aortic occlusion, or (3) by direct
coronary artery perfusion (Kirklin et al., 1979; Mentzer et al.,
2003). Shumway and associates proposed another modification
using topical hypothermia as a “safeguard” to offset ischemic
injury (Shumway et al., 1959). Unfortunately, these alternatives
were no better than the “Melrose Technique,” which was high-
lighted by Cooley’s irreversibly damaged “stone heart” (Cooley
et al., 1975).
The field of cardioprotection in the 1960s was in desperate
need of fresh ideas, innovation and improved outcomes. As a
result, scientists and surgeons began to collaborate and, in the late
1960s and early 1970s, a second wave of clinical interest in potas-
sium cardioplegia began to surface in Germany (Hoelscher, 1967;
Kirsch et al., 1972; Bretschneider et al., 1975), the UK (Hearse
and Stewart, 1974; Hearse et al., 1981) and the USA (Gay and
Ebert, 1973; Kirklin et al., 1979; Buckberg, 1993) (see Figure 2).
The collective body of experimental work was impressive and
formed the basis of today’s cardioplegia and organ preservation
solutions (Cordell, 1995; Vinten-Johansen et al., 2000; Chambers
and Hearse, 2001). Currently over 99% of cardioplegic and most
preservation solutions contain K+ concentrations over 15mEq/L
(or mM), which depolarizes the myocardial cell membrane from
a resting voltage of about −85mV (∼5mM K+) to −50mV
(Dobson, 2010). The relationship between increasing extracellu-
lar potassium concentrations andmembrane potential in the ven-
tricle during cardioplegic diastolic arrest from isolated rat, rabbit,
and guinea-pig hearts is shown in Figure 3. As we shall discuss
below, for over four decades depolarizing potassium cardiople-
gia has been a double-edged sword, particularly after Tyers and
colleagues demonstrated unequivocally that potassium, not cit-
rate, was responsible for the clinical failure of “Melrose’s method”
(Tyers et al., 1975). Depolarizing potassium solutions remain the
standard-of-care for cardioplegic arrest in cardiac surgery today.
FIVE AREAS OF CONCERNWITH HYPERKALEMIC
CARDIOPLEGIA
“Thus, although the use of elevated concentrations of potassium
to induce the rapid depolarized arrest of the heart in diastole is
by far the most widely used technique . . . it cannot be used hap-
hazardly, has a number of disadvantages, and is not necessarily the
best and most optimally protective.”
Chambers and Hearse (2001) p. 894
From a scientific standpoint, there are at least five (5) areas
of concern with potassium concentrations of 10mM and above
(Dobson, 2010): (1) unnatural membrane voltages and cellu-
lar ionic imbalances during global ischemic arrest and regional
FIGURE 3 | Cell Membranes of the Atria, Purkinje, and Ventricular
Myocytes in vivo behave as a K+ electrode over a range of
extracellular K+ from 3 to 25mM. Data were obtained from isolated rat,
rabbit, and guinea-pig hearts (Kleber, 1983; Masuda et al., 1990; Sloots and
Dobson, 2010; Dobson and Jones, 2004; Dobson, 2010) and from isolated
cells (Wan et al., 2000). The membrane potential ϕ (mV) = 27 ln [K+] − 126,
R2 = 0.97, where [K+] is extracellular potassium concentration in mM.
Membrane potentials (ϕ) were measured directly using potassium
microelectrodes (Kleber, 1983; Masuda et al., 1990; Snabaitis et al., 1997;
Wan et al., 2000) or calculated from Nerstian distributions of potassium
(Dobson and Jones, 2004; Sloots and Dobson, 2010). The relation between
potassium and membrane potential for ventricular muscle also agree well
with microelectrode measurements on isolated human atrial muscle
(Gelband et al., 1972), and for isolated purkinje fibers above 5.4mM K+
bathed in Tyrode’s solution (Sheu et al., 1980).
ischemia during reperfusion; (2) coronary vasoconstriction of
varying degrees leading to maldistribution of cardioplegia, loss
of myocardial protection and possible vascular spasm; (3) acti-
vation the coronary vascular endothelium to become leaky,
pro-inflammatory and promotes platelet aggregation; (4) post-
operative arrhythmias and conduction disturbances; and (5) a
higher incidence of low cardiac output from ventricular stunning.
ADVERSE EFFECTS OF HYPERKALEMIA ON MEMBRANE POTENTIAL
AND Ca2+ LOADING
“In (heart) fibers which do not have pacemaker characteristics,
the diastolic potential behaves as a K+ electrode and varies as
expected by the Nernst relationship when the extracellular K÷
concentration is above 3mM.”
Leonard S. Gettes (Gettes, 1976) p. 792
Hyperkalemia arrests the heart in diastole due to potassium’s
ability to reduce the availability of “open” Na+ fast chan-
nels, which are responsible for the rapid Phase O upstroke
(depolarization) of the cardiac action potential (Kleber, 1983;
Chambers and Hearse, 2001; Dobson and Jones, 2004). Cell
membranes of the atria, Purkinje fibers, and ventricles behave
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like what Leonard S. Gettes termed “a potassium electrode,”
meaning that the membrane potential during diastole is close
to a Nernstian potassium potential (Gettes, 1976) where the
sum of the net electrical and chemical concentration forces
on the potassium ion is zero [G (Al-Mehdi et al.)out/in = 0]
(Masuda et al., 1990; Veech et al., 1995). The Nernstian potential
for the isolated rat heart over a range of 3–25mM extracel-
lular K+ can be calculated from the following relation where
(Figure 3).
Membrane potential (ϕmV) = 26 ln [K+, mmol/L] + 123
(Sloots and Dobson, 2010).
The close agreement between these Nernstian estimates calcu-
lated from intra- and extracellular K+ distribution (Sloots and
Dobson, 2010), and direct K+ electrode measurements implies
that the resting membrane potential in heart muscle is predom-
inately a potassium equilibrium potential within the errors of
measurement (i.e., behaves as a K+ electrode) (Gettes, 1976).
The clinical problems associated with prolonged membrane
depolarization include Ca2+ loading of the myocyte and IR injury
(arrhythmias, stunning, inflammation, necrosis, and apoptosis)
(Suleiman et al., 2001). Depolarization-induced Ca2+ loading
occurs first from Na+ entry through the voltage-dependent Na+
fast channels. At −50mV (16mM K+), despite ∼3.5% avail-
ability of Na+ channels and only 0.1% of maximal Na+ con-
ductance compared to −80mV, the high sodium driving force
(GNa+out/in = −15KJmol−1) leads to Na+ entry via the small
Na+ “window” current that remains open at these depolarized
states (Bers et al., 2003). A rise in cell Na+ leads to a reversal of
the voltage-dependent Na+/Ca2+ exchanger (3 Na+out: 1 Ca2+
in), with a resulting rise in intracellular Ca2+ (see Figure 4).
Further Ca2+ entry can occur during Ischemia, acido-
sis and hypothermia. Global ischemia may lead to further
FIGURE 4 | A schematic of the effect of hyperkalemia and prolonged
myocardial membrane depolarization on Na+ entry through the
“window current” and the net influx of Ca2+ into the myocardial cell
via the reversal of the Na+/Ca2+ exchanger [3Na+ ions are extruded in
exchange for 1 Ca2+ entry (Bers and Despa, 2009) at a membrane
potential of −50mV (Baczko et al., 2003)]. Global or regional ischemia
and metabolic acidosis impact further on Ca2+ loading, with increases in
intracellular H+ further activating the Na+/H+ exchanger (Avkiran, 2001)
resulting in 1Na+ ion being exchange for 1 H+ ion. The diagram was
adapted from Bers and colleagues (Bers et al., 2003; Bers and Despa,
2006).
membrane depolarization from localized increases in extracel-
lular K+ (11mM or higher) (Harris et al., 1954; Gettes et al.,
1982; Kleber et al., 1987) and intracellular acidosis can acti-
vate the Na+/H+ exchanger (H+out Na+in) and Ca
2+ enters via
the Na+/Ca2+ exchanger (Na+out and Ca2+in ) (Figure 4). These
processes may be of reduced importance during surgical cardio-
plegia because metabolism (aerobic and anaerobic) has already
been slowed by: (1) electrochemical arrest, and (2) hypother-
mia. However, if subendocardial regions of the left ventric-
ular wall are not adequately perfused and protected during
cardioplegic arrest (Brazier et al., 1977), regional differences
in Ca2+ loading and ischemia-reperfusion damage may occur.
Hypothermia is also known to exacerbate the effect of ischemia
and Ca2+ loading (Sprung et al., 1995; Lathrop et al., 1998;
Gaillard et al., 2000) and alter the properties of the ventricu-
lar action potential (Figure 5). The vasoconstrictive effects of
hyperkalemia may further contribute to sub-optimal subendo-
cardial protection (see next Section). In contrast, in pediatric
cardiac surgery a very different “ischemic” scenario may exist
where the baby heart is normally arrested with a “one shot”
delivery (Allen, 2004). In this case, the heart cells are bathed
in a cold, static ischemic and depolarized state, with myocar-
dial protection becoming more compromised with time, par-
ticularly during complex corrective operations requiring longer
cross-clamp times.
Following cold ischemic arrest, as mentioned earlier, Ca2+
loading also occurs during reperfusion. There are four time-
sensitive periods of reperfusion; rewarming, reperfusing, rean-
imating and returning the heart to the general circulation.
Protecting the heart during the “4 R” periods is paramount to sat-
isfactory clinical outcome (Vinten-Johansen and Nakanishi, 1993;
Aoki et al., 1994; Liu et al., 1994; Cascio et al., 1995; Wilde and
Aksnes, 1995; Stowe et al., 2000). As the heart moves from a
cold depolarized state to a warm polarized state, it is electri-
cally and metabolically challenged because of transmural and
regional voltage heterogeneities which have to rapidly return to
their “normal” operating limits to ensure a coordinated wave
of depolarization from the SA node, atria, AV node to the ven-
tricles (see Figure 5). The effects of hyperkalemia cardioplegia,
combined with the effects of ischemia, acidosis and hypother-
mia, predisposes the heart to electrical instability during reper-
fusion which can lead to arrhythmias (Section Adverse Effects
of High K+ on Post-operative Arrhythmias and Conduction
Disturbances) and post-operative left ventricular pump dysfunc-
tion (Section Adverse Effects of High K+ on Cardiac Output
and Stunning) (Tsutsumi et al., 1983; Flack et al., 1992). These
effects of IR injury will be further exacerbated in older, sicker
patients undergoing longer cardiopulmonary bypass times, or
in complex pediatric congenital corrective operations, which
pose a serious challenge to current hyperkalemia myocardial
protection strategies.
ADVERSE EFFECTS OF HYPERKALEMIA ON CORONARY
VASOCONSTRICTION
“Cardioplegia, whether blood or crystalloid, is also intrinsically
associated with functional changes in the coronary vasculature
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FIGURE 5 | A representation of the regional sensitivities in the heart
to high potassium, and the effects of hyperkalemia, ischemia
(acidosis), and hypothermia on the ventricular action potential. The
effects were obtained from the empirical data in rabbit ventricle and
the ventricular modeling studies of Shaw and Rudy (1997) and
Cimponeriu et al. (2001). The effects of hypothermia to prolong the
action potential are from West et al. (1959), Lathrop et al. (1998) and
Coraboeuf et al. (1998; Aoki et al., 1994).
that add to the effects of cardiopulmonary bypass. This may
be observed after even routine cardiac cases, with up to 8%
of patients having coronary artery spasm manifested by tempo-
rary ST segment elevations on ECG after surgery, and an even
greater proportion exhibiting myocardial contractile dysfunction
that usually peaks 4–6 h postoperatively. These phenomena may
be seen in virtually any patient regardless of age, and irrespective
of the presence of atherosclerotic coronary artery disease or other
risk factors for endothelial dysfunction.”
(Ruel et al., 2004) p. 1002
Potassium-induced coronary vasoconstriction may result in loss
of cardioprotection by limiting cardioplegia flow and distribu-
tion to the diseased myocardium (Leicher et al., 1983; Sellke et al.,
1996; Aronson, 1999). High potassium is also linked to coronary
spasm in adults, with or without hypertension (Ruel et al., 2004)
and in pediatric patients (Nomura et al., 1997). Experimentally,
high potassium solutions have been used for over 40 years as a tool
to induce maximal vasoconstriction in aortic ring or coronary
artery conduit preparations (Norton and Detar, 1972; Kuo and
Chancellor, 1995; Sellke et al., 1996; Chong et al., 2001; Kerendi
et al., 2004).
Vasoconstriction can result from direct depolarization of vas-
cular smooth muscle or the underlying endothelium (Figure 6).
Quignard and coworkers showed that cardioplegic potassium
concentrations (15mM) depolarized vascular smooth muscle
membranes from −53 to −45mV in guinea-pig carotid and
porcine coronary arteries, which led to contraction (Quignard
et al., 1999). Casteels and colleagues further showed that the
minimal depolarization to evoke contraction of smooth mus-
cle cells isolated from the pulmonary artery was at 9.0mM KCl
(Casteels et al., 1977). Vasoconstriction can also occur from
the underlying vascular endothelium, which is electrically con-
nected to smooth muscle (Seiden et al., 2000; Han et al., 2009)
(Figure 5). Coronary vascular tone (relaxation/constriction) is
regulated by a delicate balance between endothelial vasconstric-
tive and vasorelaxive factors, which in turn modulate “end-
effector” potassium channels (KCa, Kv, and KATP channels) and
other channels located in underlying vascular smooth muscle of
the vessel wall (Figure 6) (Brayden, 1996; Han et al., 2009; Dick
and Tune, 2010). Furchgott and Zawadzki were the first to show a
link between hyperkalemia-induced vasoconstriction and impair-
ment of endothelium-derived nitric oxide (NO) release, and other
relaxation factors (Furchgott and Zawadski, 1980). Other relax-
ation factors include prostacyclin (PGI2), endothelium-derived
hyperpolarization factor (EDHF) and adenosine and/or con-
ducted hyperpolarization processes which link the endothelium
to vascular smooth muscle function (He, 2005; Wu et al.,
2005; Yang and He, 2005). He and colleagues in 2005 showed,
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FIGURE 6 | The effect of high potassium on the endothelium and
smooth muscle interactions, vasoconstriction, and possible injury.
Membrane K+ depolarization decreases the driving force for Ca2+ entry
into endothelial cells through Ca2+-activated K+ channels (Coleman et al.,
2004), increases voltage sensitive endothelial NADPH oxidases (and other
oxidants) (Sellke et al., 1993; Li and Shah, 2004) which can lead to vascular
smooth muscle contraction and vasoconstriction (van Breemen et al., 1997)
from a reduced availability of endothelial-derived vasodilators [prostacyclin
(PGI2), nitric oxide (NO), non-NO/PGI2 relaxation factors (EDHF’s) and
adenosine] (He, 2005; Wu et al., 2005; Yang and He, 2005). Hyperkalemia
in cardioplegia has been linked to loss of ACh-dependent relaxation, which
may be exacerbated by ischemia and hypothermia (Tyers, 1997; Parolari
et al., 2002; Yang and He, 2005).
for example, that incubating porcine small resistance coronary
arteries in either St. Thomas’s solution or Celsior preservation
solutions resulted in a significant potassium-induced depolar-
ization and loss of endothelial-derived hyperpolarizing factor
(EDHF)-mediated function (Wu et al., 2005; Yang and He, 2005).
The endothelium-derived vasoconstrictor Endothelin-1 may con-
tribute to vasoconstriction (Feng et al., 2010), as it is involved in
ischemia-reperfusion injury, spasm and transient left ventricular
dysfunction following hyperkalemic arrest (Knothe et al., 1992;
Dorman et al., 2000).
Magnesium is often added to cardioplegia to reduce intracellu-
lar Ca2+ loading during ischemia (Nakaigawa et al., 1997; Ichiba
et al., 1998; Murphy, 2000; Mubagwa et al., 2007) and to counter
K+-induced vasoconstriction (Matsuda et al., 1999; Yang and He,
2005). Colder temperatures also offset the vasoconstriction effects
of high potassium (Chiavarelli et al., 1982), however, it can lead
to local and systemic inflammation, coagulation disturbances and
tissue edema (Mezzetti et al., 1995; Torracca et al., 1996; Gaillard
et al., 2000; Torchiana et al., 2000; Ravishankar et al., 2003). Thus,
while hypothermia partially mitigates the potassium constrictor
property, it may not provide optimal myocardial protection in
cardiac surgery.
ADVERSE EFFECTS HYPERKALEMIA ON MYOCARDIAL ENDOTHELIAL
FUNCTION
“Modern cardiopulmonary bypass and cardioplegic arrest tech-
niques remain associated with an acute transcriptional response
of hundreds of genes that primarily effect the largest organ of
the body, the endothelium, as well as other constituents of blood
vessels.”
(Ruel et al., 2004) p. 1002
The endothelium sits at the geographical nexus between the blood
and myocardium and has an exceptionally high surface area of
∼35m2 in the adult heart for only ∼3% of the total myocar-
dial volume (Hearse and Stewart, 1974; Verma and Anderson,
2002). Along with high potassium’s vasoconstrictive and spas-
modic effects (discussed above), K+ levels as low as 10mM K+
have been linked to endothelial injury including vascular depo-
larization, inflammation, neutrophil adherence, leaky junctions,
platelet activation, pro-oxidant production, and impaired coag-
ulation status (Jellinek et al., 1981; Mankad et al., 1991, 1997;
Nilsson et al., 1993; Sellke et al., 1993; Parolari et al., 2002; Verma
and Anderson, 2002; Perrault and Carrier, 2005; Higashi et al.,
2009) (Figure 6).
As early as 1981 Jellinek and colleagues showed that high
potassium (>30mM) led to structural changes in endothelial
cells such as intracellular vacuolization and blebbing with vacuole
formation, and that these deleterious effects were reduced with
hypothermia (Jellinek et al., 1981). In the same year, Carpentier
et al. (1981) reported that depolarizing potassium cardioplegia
markedly reduced the viability of human endothelial cells and
fibroblasts after several hours of incubation. Hoover and col-
leagues further demonstrated in vein grafts exposed to potassium
solution that there was an aggressive adventitial fibrotic reaction
compared to a control normokalemic Ringer’s solution (Hoover
et al., 1981). In 1983, Olinger and others showed in their pri-
mate model of graft atherogenesis that prolonged exposure of
the cephalic vein grafts to hyperkalemic crystalloid cardioplegic
solutions (27mM KCl) resulted in increased lipid uptake and
cholesterol deposition in the subintimal space 12 weeks after
surgery (Olinger et al., 1983). It is possible that high potas-
sium lead to intimal damage and loss of patency in the 16–25%
of saphenous vein conduits that occur in the first post-surgical
year, and 10% of occlusions in radial artery grafts (Goldman
et al., 2004; Magee et al., 2008; Buxton et al., 2009). This associa-
tion between depolarizing hyperkalemia and graft failure requires
further investigation.
While the mechanisms of high K+-induced endothelial dam-
age are controversial, it appears that membrane depolarization
is a first step of injury and activation and oxidant production
(Figure 6). Membrane depolarization increases voltage sensitive
endothelial NADPH oxidases (and other oxidants) and con-
tributes to oxidative injury and endothelial activation (Sellke
et al., 1993; van Breemen et al., 1997; Li and Shah, 2004). Many
years ago, Yacoub and colleagues reported that increasing the con-
centration in St. Thomas’s solution (Plegisol®) or Bretschneider’s
(HTK, Custodiol®) solution from 20 to 30mM played a critical
role in causing endothelial damage, which was assessed as a loss
of endothelium-dependent vasodilation (Mankad et al., 1991).
In 2008, Radovits and colleagues stored isolated rat aortic rings
for 24-hour in cold traditional Bretschneider’s solution [HTK,
Custodiol®], and reported endothelial dysfunction (Radovits
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et al., 2008). In 1993, Sellke and others showed that coronary
endothelial dysfunction after ischemic cardioplegic arrest and
cardiopulmonary bypass, and it was also involved with the pro-
duction of oxygen-derived free radicals (Sellke et al., 1993).
Endothelial membrane depolarization is known to promote
platelet adhesion and neutrophil activation and inflammation
(Niu et al., 1996; Halkos et al., 2004; Li and Shah, 2004).
Interestingly, as early as 1987 Ishikawa and Sasakawa showed
that increasing K+ led to increasing depolarization of platelets,
and that aggregation induced by ADP or collagen was enhanced
by depolarization with increasing extracellular [K+] (Ishikawa
and Sasakawa, 1987). In 2003, Krotz and colleagues similarly
showed that endothelial membrane depolarization promoted
platelet aggregation through increased superoxide production
(O−2 ) and inactivation of endothelial ectonucleotidases, and this
effect was abolished bymembrane hyperpolarization (Krötz et al.,
2003). In 2005, Matsuzaki et al., further reported membrane
depolarization-induced ROS generation when rat and mouse
endothelial cells were switched from a normokalemic (5.9mEq
K+) to a hyperkalemic bathing solution (24mEq K+) (Matsuzaki
et al., 2005). Platelet aggregation and neutrophil adhesion are
thought to be key events in inflammation and acute vascu-
lar thrombosis, particularly when activated platelets come into
contact with the subendothelial matrix, like collagen (Siess, 1989).
High K+ also promotes tissue oxidative stress, which may lead
tomyocardial ischemia-reperfusion injury and exacerbate inflam-
mation (Figure 6). Al-Mehdi and colleagues have employed high
potassium to convert lung cells from a normal to pro-oxidant
state (Al-Mehdi et al., 1997, 1998). These workers showed in
the intact lung or reconstituted cell systems that high potas-
sium triggered a depolarization-linked activation of endothelial
NADPH oxidase and extracellular generation of O−2 (Al-Mehdi
et al., 1997, 1998). In 2000, Sohn and others also used high potas-
sium (90mM) to depolarize human endothelial cells, and found
that the extent of depolarization of the membrane was directly
responsible for the production of superoxide (O−2 ), and that the
effect was inhibited in the presence of a hyperpolarizing KATP
channel opener (HOE 234) (Sohn et al., 2000). Furthermore, pre-
treatment with the tyrosine kinase inhibitor genestein completely
abolished the K+ depolarization-induced production ofO−2 , indi-
cating an involvement of tyrosine phosphorylation (Sohn et al.,
2000) (Figure 5). Thus, there is a strong association between
high potassium cardioplegia, endothelial activation, and oxidant
stress which may lead to post-operative cardiac and vascular
dysfunction.
ADVERSE EFFECTS OF HYPERKALEMIA ON POST-OPERATIVE
ARRHYTHMIAS AND CONDUCTION DISTURBANCES
“Potassium, calcium, sodium, and magnesium play a role in the
genesis of experimental arrhythmias. In the clinical setting, how-
ever, altered K+ concentration is responsible for the vast majority
of such arrhythmias. This is true because within the range of levels
of various electrolytes encountered in clinical disorders, K+ is the
electrolyte most likely to alter the electrophysiologic properties of
the heart.”
Fisch C (1973) (Fisch, 1973)
Early postoperative arrhythmias are a frequent complication
of adult and pediatric cardiac surgery (Harris et al., 1954; Ebert
et al., 1962; Flack et al., 1992; Cohen et al., 1993; Yau et al., 1993;
Gaillard et al., 2000; Valsangiacomo et al., 2002). In 1980, Ellis
showed that higher potassium concentrations in cardioplegia in
humans resulted in a higher number of ventricular arrhythmias
following cross-clamp removal, and this was worse at lower tem-
peratures (Ellis et al., 1980). Post-operative arrhythmias can lead
to left ventricular dysfunction, hemodynamic deterioration and
costly treatment regimens amounting to billions of dollars per
annum in the USA alone (Aranki et al., 1996; Mathew et al.,
2004; Steinberg, 2004; Echahidi et al., 2008; Anselmi et al., 2009).
Arrhythmias are also a major cause of morbidity and mortality
in pediatric patients (Lan et al., 2003), where the overall inci-
dence of arrhythmias can be as high as 48% (Pfammatter et al.,
2002; Valsangiacomo et al., 2002). We are unaware of any stud-
ies having investigated the role of hyperkalemic cardioplegia on
the incidence of early post-operative arrhythmias in the pediatric
patient.
High potassium-linked arrythmogenicity is related to the
creation of abnormal regional and transmural electrical het-
erogeneities required for the normal conduction of the heart
(Figure 5). It has been known for over 40 years that the atria
are the most sensitive to high K+ (de Mello and Hoffman, 1960),
followed by ventricular cells, His cells, SA nodal cells, and inter-
atrial tracts (Ettinger et al., 1974) see (Figure 5). That the SA
node is more resistant to increasing K+ explains why nodal
activity persists after early cardioplegic arrest of the atria and
ventricles. Thus, differences in regional and wall potassium sensi-
tivities, combined with localized K+ changes from cold ischemia
and diastolic membrane voltage changes, may give rise to new
onset arrhythmias following cardiac surgery. Tsutsumi and col-
leagues further showed differences in K+ sensitivity across the
wall of the ventricle at the base and near the apex of the heart
(Tsutsumi et al., 1983). Higher K+ resulted in greater decreases in
repolarization times in the basal epicardium compared with the
endocardium, and a greater decrease at the endo vs. epicardium
near the apex (Tsutsumi et al., 1983). Abnormal times for ven-
tricular repolarization (Figure 5), along with local conduction
slowing, may be key factors in predisposing the heart to arrhyth-
mias during reanimation (Ettinger et al., 1974; Tsutsumi et al.,
1983).
Depolarizing potassium can also lead to conduction (SA,
AV, and Bundle of His) disturbances (Taggart et al., 2000).
From the early 1980s, there were many groups investigating the
failure of standard high potassium cardioplegia and hypother-
mic techniques to protect the heart’s conduction system dur-
ing cardiac surgery (Ellis et al., 1980). Ferguson and colleagues
using multiple bipolar intracardiac and unipolar intramural elec-
trodes reported the presence of electrical activity in the lower
atrial septum, the atrioventricular node-His bundle complex,
and in ventricular myocardium during hyperkalemic cardio-
plegic arrest that interestingly could not be detected visually
or on the limb-lead electrocardiogram (Ferguson et al., 1986).
Magilligan and colleagues suggested additional local cooling was
needed at specific sites to reduce the incidence of conduction
disturbances, block and junctional rhythm and low ventricular
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output following reperfusion (Magilligan et al., 1985; Ferguson
et al., 1986). In summary, regional hyperkalemia and sensitivities
(Figure 5), may induce regional refractroriness and local con-
duction slowing, which predispose the heart to post-operative
arrhythmias.
Could the effect of hyperkalemia, hypothermia, and electrical
disturbances contribute to post-operative atrial fibrillation (AF)?
As mentioned in the introduction, AF is an early comorbid event
with an incidence of around 30% after CABG and as high as 69%
after more complex procedures (Almassi et al., 1997; Steinberg,
2004; Scherr et al., 2006). At present it is unclear whether high K+
in cardioplegia is directly linked to post-operative AF (Mathew
et al., 2004; Steinberg, 2004; Echahidi et al., 2008; Anselmi et al.,
2009), as similar incidences occur following “on-pump” and “off-
pump” where no hyperkalemic cardiopelgia is used (Hosokawa
et al., 2007). However, it is possible that the underlying causes
of AF in both types of surgery have direct and indirect roles for
depolarizing K+ in a setting of ischemia-reperfusion, endothelial
dysfunction and inflammation (Vinten-Johansen et al., 2007a).
In “on-pump surgery,” AF could be exacerbated from high K+
in the surgical cardioplegia, and in “off-pump” surgery from
rises in local extracellular K+ from multiple bouts of regional
ischemia during occlusion of the target vessel, and from the
compounding effect of acidosis which can activate endothelial
cells to produce damaging oxidants and amplify the inflam-
matory process (Kitagawa and Johnston, 1985; Al-Mehdi et al.,
1997). Regional ischemia can lead to increases in extracellu-
lar K+ of over 20mM, and Miura’s group showed that these
changes are linked to non-uniform rises in intracellular Ca2+
and sustained arrhythmias (Miura et al., 2012). In 2008, Kon and
colleagues also reported a strong correlation during “off-pump”
cardiac between myocardial ischemia and gradients of transcar-
diac inflammation markers (TNF-alpha, IL-8) and thrombosis
(thrombin generation-F1.2, contact activation pathway-FXII-a,
platelet derived microparticles) (Kon et al., 2008). This data sug-
gests that even brief episodes of ischemia-reperfusion during
off-pump surgery may cause local injury currents in the atria,
which may be significant because the atria are the most sensi-
tive to high K+ (Figure 5). In 2009, Tran and colleagues also
reported a link between plasma K+ during cardiac surgery and
post-operative atrial fibrillation (Tran et al., 2009). Thus, hyper-
kalemia, whether imposed on the heart from depolarizing K+ in
surgical cardioplegia or from bouts of regional ischemia during
beating heart surgery, may be linked functionally to membrane
depolarization and an activated endothelium and inflammatory
response, which collectively promote the generation of atrial (and
ventricular) arrhythmias. Further studies are required to test this
hypothesis.
ADVERSE EFFECTS OF HYPERKALEMIA ON CARDIAC OUTPUT AND
STUNNING
“There is clinical evidence that myocardial stunning is a frequent
sequela of surgical global ischemia, despite our modern tech-
niques of myocardial protection. The ubiquitous usage of hyper-
kalemic depolarizing solutions in all forms of cardioplegia may
be partly responsible for this phenomenon because of the known
ongoing metabolic requirements and damaging transmembrane
ionic fluxes that occur at depolarized membrane potentials.”
Damiano RJ Jr, Cohen NM. (Damiano and Cohen, 1994)
Left Ventricular dysfunction is a key determinant of patient
outcome following cardiac surgery (Algarni et al., 2011). One
form of post-operative LV dysfunction is myocardial stunning
or the loss of post-operative contractility from IR injury with-
out cell death (Braunwald and Kloner, 1982; Kloner et al.,
1994). The phenomenon was first described experimentally in
1975 by Heyndrickx and colleagues, who reported an abnormal,
depressed ventricular function after regional ischemia in dogs
despite normal return of coronary blood flow and ECG wave-
form (Heyndrickx et al., 1975). It is manifest as a decrease in
cardiac output typically lasting 2–4h post-operatively (Gillies
et al., 2005), and can persist for longer periods without apparent
signs of infarction or other serum injury markers (Troponins or
CKMB) (Kloner and Jennings, 2001). Stunning occurs in about
10% of adults following cardiac surgery (Weisel, 1993; Vaage and
Valen, 1993; Mangano, 1995; Spinale, 1999; Flack et al., 2000;
Chang et al., 2002; Anselmi et al., 2004) and in 10–15% of pedi-
atric patients (Parr et al., 1975; Booker, 1998; Ravishankar et al.,
2003). Stunning may contribute to low cardiac output syndrome
(LCOS) in adults (Algarni et al., 2011) and pediatric patients
(Weisel, 1993; Booker, 1998; Spinale, 1999; Wessel, 2001; Allen,
2004; Jones et al., 2005). The incidence of LCOS occurs int 3–14%
of adult CABG patients and is associated with a 10-fold to 17-
fold increase in mortality (Algarni et al., 2011), and in around
25% of pediatric cardiac surgery patients (Jones et al., 2005).
The classic features of LCOS include tachycardia, oliguria, poor
peripheral perfusion, and low blood pressures (Jones et al., 2005).
Importantly, a low ejection fraction (EF) is a poor predicator
of overall cardiac reserves and does not predict LCOS (Zaroff
et al., 1994), however, a low EF plus inadequate cardioprotection
is associated with LCOS and possible stunning (Zaroff et al., 1994;
Aronson, 1999).
Hyperkalemic cardioplegia may contribute to myocardial
stunning and LCOS from the effect of high potassium and IR
injury on Ca2+ loading, vasoconstriction, reanimation arrhyth-
mias, and endothelial dysfunction (Figures 3–6) (Booker, 1998;
Allen, 2004; Amark et al., 2005). In animal models cold hyper-
kalemic cardioplegia, and the transition from hypothermia to
normothermia, before cross-clamp removal is also a factor linked
to stunning (Przyklenk et al., 1994; Spinale, 1999; Eberhardt
et al., 2000; Ambrosio and Tritto, 2001). An area of particular
interest in stunning is the release of catecholamines from adren-
ergic nerve terminals leading to further transient Ca2+ loading
(Lubbe et al., 1992; Paterson et al., 1993; Vatner and Vatner,
1998; Lameris et al., 2000; Vittone et al., 2006), and the produc-
tion of oxidants and oxygen-derived free radicals from injured
myocytes and activated endothelial cells exacerbating inflamma-
tion and coagulation imbalances (Bolli et al., 1988; Carden and
Granger, 2000; Kloner and Jennings, 2001; Zweier and Talukder,
2006). The direct and indirect roles of high potassium as part of
the underlying pathophysiology of myocardial stunning warrant
further investigation (Algarni et al., 2011).
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FIVE DECADES OF SEARCHING FOR ALTERNATIVES TO
DEPOLARIZING POTASSIUM
“Nothing is new except arrangement.”
Will Durant (1885–1981).
For over five decades, surgeons and scientists have acknowledged
the adverse effects of high potassium cardioplegia (Chambers and
Fallouh, 2010) (Figure 2). After a 10 year “moratorium” begin-
ning in the late 1950s, Bretschneider and colleagues began to
test alternatives, and in 1967 they hypothesized that dramatically
reducing sodium (from ∼130mM to 12mM) and keeping Ca2+
low (near zero), and reducing potassium in the presence of the
Class 1 antiarrhythmic agent procaine (0.2%) may offer a safer
and effective way to inhibit the action potential and arresting
the heart (Reidemeister et al., 1967). In the same year, Hoelscher
tested procaine as a non-depolarizing arresting agent in rabbit
hearts, and confirmed that the “Melrose technic” using potas-
sium citrate was pro-arrhythmic and caused severe myocardial
damage (Hoelscher, 1967). In 1972, Kirsch proposed another car-
dioplegia formulation containing procaine, magnesium aspartate,
and sorbital with apparently good clinical results (Kirsch et al.,
1972). However, in 1977 Jynge et al. evaluated the components
of the Kirsch and Bretschneider solutions using dose response
curves, and compared the efficacy with their own home-grown St.
Thomas’ Hospital solution with 15mM KCl and 16mM MgCl2
(Jynge et al., 1977). Using the isolated Langendorff rat heart
model, they concluded that the St Thomas Hospital solution had
superior in functional recovery (Jynge et al., 1977). Jynge and
colleagues further cautioned the field that until the mechanisms
underlying ischemic damage were better understood, it would be
unwise to recommend “the use of solutions containing extremes
of concentration or solutions devoid of ions normally found in
the extracellular fluid” (Jynge et al., 1977). St Thomas’ Solution
was introduced clinically in 1975.
In the 1970s the science of cardioplegia began to expand and
diversify. In 1975 Tyers and associates introduced tetrodotoxin
as another cardioplegia agent in the isolated rat heart (Tyers
et al., 1975). Tetrodotoxin was first shown in 1960 by Narahashi
to polarize the cell membrane, presumed by blocking sodium
channels (Narahashi et al., 1960; Narahashi, 2008), and in
1997 Chambers and colleagues extended Tyers studies (Snabaitis
et al., 1997). In 1983, Leicher and colleagues also tested blood
cardioplegia using (1) 1.5mM lidocaine alone, (2) 1.5mM
lidocaine with 30mM potassium, and (3) 30mM potassium
alone, and they concluded that high K+ cardioplegia causes
marked vasoconstriction, and impairs cardioplegic delivery and
distribution (Leicher et al., 1983) (Figure 2). As a primary
cardioplegic agent, lidocaine alone has not translated into sur-
gical practice (Yamaguchi et al., 2007), however, the drug is
commonly used at lower concentrations with or without mag-
nesium during reperfusion to reduce ventricular arrhythmias
(Baraka et al., 1993; Kanchi et al., 2004; Yamaguchi et al.,
2007).
Another non-depolarizing cardioplegic agent was adenosine.
In 1989, Opie and colleagues tested 10mM adenosine in the
isolated rat heart (Schubert et al., 1989). Belardinelli had pre-
viously shown that 50μM adenosine inhibited isolated rabbit
SA node pacemaker cells by hyperpolarizing the membrane by
∼12mV (Belardinelli and Giles, 1988). Opie and colleagues
reported that high doses of adenosine induced rapid arrest but
delayed post-ischemic recovery, and after assessing all the data
they advocated switching back to depolarizing potassium cardio-
plegia with adenosine as an adjunct (De Jong et al., 1990). This
work formed the basis for Phase I and II clinical trials in the
late 1990s (Mentzer et al., 1999). Unfortunately, the trials showed
no significant cardioprotective advantage of having adenosine
present in hyperkalemic blood cardioplegia (Mentzer et al., 1997,
1999; Cohen et al., 1998; Vinten-Johansen et al., 2003). In 2007,
Jacobsen and colleagues have shown that 1.2mM adenosine
instead of supranormal potassium in cold-crystalloid cardioplegic
solution improved cardioprotection in the porcine model of car-
diopulmonary bypass (Jakobsen et al., 2007). More recently, the
same group showed in humans that the adenosine cardioplegia
resulted in shorter times to arrest (11 vs. 44 s, P < 0.001) and
lower postoperative atrial fibrillation (19 vs. 54% p = 0.01) com-
pared with high potassium cardioplegia (20mM) (Jakobsen et al.,
2013). The discrepancy between Jacobsen’s and previous adeno-
sine cardioplegia studies (Schubert et al., 1989; Mentzer et al.,
1999; Vinten-Johansen et al., 2003; Ahlsson et al., 2012) may be
explained by their addition of local anesthetic (procaine) (Vinten-
Johansen and Dobson, 2013). Dobson and colleagues have shown
that adenosine plus a local anesthetic confers superior protec-
tion than adenosine alone (Dobson and Jones, 2004) (see Section
Adenosine and Lidocaine (AL): A More Natural Way to Arrest,
Protect, and Preserve the Heart). Dobson chose lidocaine because
as a Class 1B anti-arrhythmic it shortens repolarization time,
whereas procaine (Class 1A) prolongs repolarization time (Opie
and Gersh, 2008), which may cause post-operative reanimation
irritability (Vinten-Johansen and Dobson, 2013).
In the 1990s, ATP-sensitive potassium (KATP) channel open-
ers were another class of drugs that raised the interest of surgeons
as alternatives to hyperkalemia (Figure 1). Following Noma’s dis-
covery of the KATP channel in heart in 1983 (Noma, 1983), a num-
ber of KATP openers were subsequently developed (e.g., pinacidil,
aprikalim, nicorandil, and cromakalim), and they shared the
property of hyperpolarizing the cell membrane of a number
of tissues, including myocardium (Nichols and Lederer, 1991).
At high concentrations, KATP channel openers prevented the
Na+ fast channels from reaching their threshold to open and
thereby arrested the heart in asystole (Chambers and Hearse,
2001). Initially there was great excitement about the possibil-
ity of KATP openers as primary non-depolarizing cardioplegic
agents (Cohen et al., 1993, 1995; Lopez et al., 1996; Jayawant
et al., 1997; Jayawant and Damiano, 1998). Unfortunately, like
many new drugs, their application did not translate to clinical
safety and efficacy because they failed to protect the myocardium,
and many were pro-arrhythmic during reperfusion (Chi et al.,
1990; Chambers and Hearse, 1999). The field had come full circle;
non-depolarizing agents such as procaine and lidocaine, hyperpo-
larizing agents such as adenosine and KATP openers, once again
became servants to high potassium concentrations. They were
principally experimentally and in some cases clinically used as
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adjuncts in hyperkalemic cardioplegic solutions and longer-term
preservation solutions, rather than the primary arresting agents
(McCully and Levitsky, 2003; Diodato et al., 2005; Mizutani et al.,
2006).
Other arresting agents have been experimentally examined
and reexamined over the past 50 years, including acetylcholine
(Lam et al., 1958), calcium antagonists (verapamil, nifedipine,
and diltiazem) (Robb-Nicholson et al., 1978), high concentra-
tions of magnesium (Kirsch et al., 1972), other sodium channel
blockers (Snabaitis et al., 1997), 2,3-Butanedione monoxime
(Chambers, 2003) and opioids (Bolling et al., 1997). More
recently, non-depolarizing esmolol-HCl cardioplegia has been
suggested as a possible alternative to high potassium (Warters
et al., 1998; Chambers, 2003). Esmolol-HCl is an ultra-short-
acting beta-blocker with a half-life of about 10min, and at high
concentrations can both arrest the heart and attenuate myocardial
ischemia-reperfusion injury (Geissler, 2002; Chambers, 2003).
Although Chambers showed that multidose infusions (2min
given every 15min) of a 1.0mmol/L esmolol solution arrested
and protected isolated crystalloid-perfused rat hearts for up to
90min at normothermic temperatures (Chambers, 2003), earlier
work by Deslauriers and colleagues (Ede et al., 1997) reported
esmolol-related increases in left ventricular diastolic pressure and
pulmonary arterial pressures during arrest, and a difficulty in
weaning the pigs off bypass (Ede et al., 1997). Further work is
required to test the surgical applications of esmolol in the clinical
setting.
ADENOSINE, LIDOCAINE, AND Mg2+ (ALM™): A MORE
NATURAL WAY TO ARREST, PROTECT AND PRESERVE THE
HEART
“For any question in science, there is one animal best suited to
study it”
August Krogh [quoted from Krebs (1975)].
LESSONS FROM NATURAL HIBERNATORS
In the late 1990s, one of us (GPD) asked the question: “Could
the human heart be pharmacologically modified to operate more
like the heart of a natural hibernator during cardiac surgery?”
(Dobson, 2004). The question taps into hundreds of millions of
years of animal adaptations from Nature’s own laboratory with
the goal of developing new strategies and therapeutics to treat
human disease. Wilfred Bigelow used the “August Krogh” prin-
ciple in 1950 when he first introduced therapeutic hypothermia
into cardiac surgery by recalling his experience as a boy in Canada
and natural hibernators dropping their core temperatures to a few
degrees above ambient (Bigelow, 1984). Bigelow wrote: “I became
aware that surgeons would never be able to correct or cure heart
conditions unless they were able to stop the circulation of the
blood through the heart, open it, and operate in a bloodless field
under direct vision” . . . “One night I awoke with a simple solution
. . . cool the whole body, reduce oxygen requirements, and interrupt
the circulation and open the heart” (Bigelow, 1984; Sealy, 1989).
With respect to slowing the heart, natural hibernating ani-
mals (or summer estivators) do not flood their heart cells with
high K+ and depolarize their cell membranes as they enter tor-
por, hibernation or estivation (Willis et al., 1971; Al-Badry and
Taha, 1983; Wang et al., 2002; Dobson, 2004). As tempera-
ture drops from 35 to 10◦C, myocytes from the rat depolarize
from about −80 to −45mV see (Wang et al., 2002), whereas
myocytes from the hibernating ground squirrel can be super-
cooled to −5◦C and defend their membrane potential at around
−60mV (Wang and Zhou, 1999). Furthermore, natural hiberna-
tors do not vasoconstrict their coronary arteries with depolarizing
K+, and potentially compromise blood flow distribution and
myocardical protection during hibernation (Sjöquist et al., 1986;
Burlington et al., 1989; Kudej and Vatner, 2003; Dobson, 2004).
Studies on woodchucks (Marmota monax) have shown that coro-
nary blood flow was maintained despite an 84% fall in cardiac
output during hibernation relative to the awake state (Kudej and
Vatner, 2003).Thus, from the lessons of natural hibernators, the way
surgeons have imposed depolarized, low energy states on the human
heart and coronary vasculature using high K+ is unphysiological
on at least two accounts: (1) hibernators reduce their metabolism
without imposing a depolarizing insult on their cells, and (2)
the coronary arteries of hibernators are left wide open despite a
low-energy torpid state of the heart.
THE AL(M) POLARIZING CONCEPT
Down-regulating the heart during hibernation may involve
multi-modulation of Na+ channel activity and associated innate
central nervous system-linked-cell preconditioning mechanisms
with the production of KATP channel openers or O2 demand-
lowering agents by endogenous agents that are released during
low oxygen transition states such as naturally occurring adeno-
sine. Adenosine has been shown to be important in priming the
brain for entrance into hibernation in the arctic ground squir-
rel (Jinka et al., 2011). The two drugs chosen to mimic the
hibernating heart and examined 10 years ago from a long list
of energy lowering compounds, K+ATP openers, and Na
+ blockers
were adenosine and lidocaine (see Figure 7).
The AL polarizing hypothesis was formulated in 1998 and
based on the following reasoning. If the voltage-amplitude (Phase
O upstroke) of the cardiac action potential was reduced to its dias-
tolic baseline by blocking the inward Na+ fast current (y-axis),
and if the action potential duration of the atria, Purkinje fibers,
and ventricles were reduced by opening KATP channels (x-axis)
(see Figure 5), the heart should arrest at its “resting” diastolic
membrane potential of −80 to −85mV (Dobson, 2004). There
would be no need for depolarizing potassium to induce electro-
chemical arrest. Along with adenosine opening KATP channels
(Terzic et al., 1995) and lidocaine blocking Na+ fast channels
(Josephson, 1988; Moller and Covino, 1988; Zamponi et al.,
1993; Opie and Gersh, 2008), the additional benefit of arresting
(and non-arresting) concentrations of A and L is that they both
rapidly and reversibly slow heart rate (negative chronotropism)
(Drury and Szent-Gyorgyi, 1929) (Wilson et al., 1993; Belardinelli
et al., 1995), slow atrioventricular conduction (negative dro-
motropism) (Smith, 1989; Pitkanen et al., 1992; Wagner et al.,
1998; Davies, 1999; Canyon and Dobson, 2004; David et al.,
2007), and they each possess coronary vasodilatory (Berne,
1963; Schrader, 1990; Ely and Berne, 1992; Travis et al., 1999),
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FIGURE 7 | Summary of the major properties and structures of adenosine and lidocaine (with Mg2+), and their potential mechanisms of action for
heart arrest, protection and preservation (see text for details).
anti-ischemic (Tosaki et al., 1988; Lasley et al., 1990; Downey
et al., 1993; Kamiyama et al., 1995; Jovanovic et al., 1997, 1998;
McCully et al., 1998; Vinten-Johansen et al., 1999, 2005; Kanchi
et al., 2004; Hove et al., 2007; Wang et al., 2007), anti-arrhythmic
(Camm and Garratt, 1991; Alexander et al., 1999; Kucera et al.,
2002; Wyman et al., 2004; Jacobson and Gao, 2006) and anti-
inflammatory properties (Goldstein et al., 1977; McGregor et al.,
1980; Tomoda et al., 1990; Sasagawa, 1991; Cronstein et al., 1992;
Das and Misra, 1992a,b; Mikawa et al., 1997; Vitola et al., 1997;
Hollmann and Durieux, 2000; Hollmann et al., 2001; Huang
et al., 2002; De Kalver et al., 2003; Vinten-Johansen et al., 2003;
Halkos et al., 2004; Hasko and Cronstein, 2004; Hollmann et al.,
2004; Lenfant et al., 2004; Lappas et al., 2005; Amir et al., 2006;
Cassuto et al., 2006; Takahashi et al., 2007; Hasko et al., 2008)
and possible coagulation correcting effects (Cooke et al., 1977;
Borg andModig, 1985; Stewart, 1993; Deguchi et al., 1998; Tobias
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et al., 1999; Hollmann and Durieux, 2000; Broussas et al., 2002;
Pinet et al., 2002; Evans et al., 2003; Lappas et al., 2005; Sands
and Palmer, 2005; Kreckler et al., 2006) (see Figure 7). Possible
cross-talk between A and L may also occur as was recently shown
by Benkwitz et al. (2003). Since the adenosine receptors and Na+
fast channels are common among most tissues of the body, the
clinical applicability of the AL (and Mg2+) concept may confer
multi-organ protection such as brain, spinal cord, kidney, liver,
GI tract, muscle, and lung (Figure 7).
ADVANTAGES OF POLARIZED vs. DEPOLARIZED ARREST AND
REANIMATION
“Thus maneuvers that precluded activation of the Na+ channels,
for example, holding the resting membrane potential at −80mV
significantly increased time to cell death or prevented contracture
entirely.”
Ward et al. (2006)
The advantage of the polarized arrest and reanimation con-
cept arises from fewer membrane channels, pores and exchang-
ers being open or activated compared with the depolarized
state (Chambers and Hearse, 2001; Dobson and Jones, 2004).
Depolarised cells are electrically more unstable because many
voltage-dependent membrane channels (Ca2+, Na+ window cur-
rent, K+), pores and exchangers (Na+/H+ and Na+/Ca2+) are
activated (Kondo, 1987; Carmeliet, 1999; Baczko et al., 2003),
which can lead to Na+ and Ca2+ loading, endothelial activa-
tion, coronary artery constriction, arrhythmias and stunning. As
mentioned earlier, high K+-induced membrane depolarization
can lead to the superoxide production in endothelial and vas-
cular smooth muscle cells, platelet aggregation, macrophage and
neutrophil activation (Sohn et al., 2000), and underlying tissue
damage (Al-Mehdi et al., 1997). In 2006, Ward and colleagues
(Ward et al., 2006) reported that emigrated neutrophils, after
adhering to ventricular myocytes, caused an immediate mem-
brane depolarization, which contributed to an inflammatory-
linked generation of arrhythmias, tissue injury and contractile
dysfunction (Ward et al., 2006). Ward et al., further showed that
holding the cell membrane potential around the natural “resting”
polarized state reduced damage from inflammatory attack (Ward
et al., 2006). Thusmaintaining a “polarized”membrane potential,
or at least stabilizing the voltage during times of stress like global
and regional ischemia, appears to be a key factor in preventing the
endothelium from activating and triggering a local inflammatory
response with increased levels of pro-inflammatory cytokines (IL-
1, IL-6, and TNF-α) and other immunologic and coagulopathic
derangements.
PLACING THE HEART IN A “NATURAL” STATE OF THERAPEUTIC
SUSPENDED ANIMATION
AL cardioplegia: pre-clinical data
Our early preclinical data using the isolated rat heart (Dobson
and Jones, 2004) and in the canine model of cardiopulmonary
bypass (Corvera et al., 2005) supported the AL concept as a new
cardioplegic formulation in warm and cold crystalloid and blood
environments. In 2004, Dobson and Jones showed that AL car-
dioplegia, “clamped” the membrane potential close to its resting
voltage of−83mV, as was predicted on theoretical grounds. They
also showed that AL cardioplegia arrested the heart for up to 4 h
at 29◦C with small 30% increases in coronary vascular resistance
(CVR), 85–100% recovery of heart rate and systolic pressure, and
70–80% recovery of cardiac output, while only 17% of hearts
arrested with St. Thomas’ Hospital solution No 2 (Plegisol®)
survived (Dobson and Jones, 2004). Proof-of-concept was fur-
ther demonstrated using all-blood AL cardioplegia in the canine
model of cardiopulmonary bypass (Corvera et al., 2005), and in
2007, we reported that AL cardioplegia can be delivered con-
tinuously or intermittently at 33◦C with no significant loss in
functional parameters (Sloots et al., 2007).
In 2010 Sloots and Dobson (Sloots and Dobson, 2010) exam-
ined the effect of varying levels of extracellular potassium in AL
cardioplegia (0.1, 3.0, 5.9, 10, 16mM K+) on the membrane
potential (ϕ), CVR, incidence of arrhythmias, heart rate, sys-
tolic pressures, aortic and coronary flows, cardiac output, time to
first beat, and stroke volume after 1 and 2 h of arrest at 32–33◦C
(Figures 8A–C). Sloots and Dobson showed that warm AL car-
dioplegia is most efficient under normokalemic conditions when
the myocardial cell membrane potential is close to its resting state.
Hearts arrested using higher K+ levels (depolarizing cardioplegia)
or interestingly, using lower K+ levels (hyperpolarizing cardio-
plegia), had significantly higher CVR’s, experienced reanimation
arrhythmias and were “slow-to-recover” with significant losses in
left ventricular (LV) function, SV and contractility (Sloots and
Dobson, 2010). LV functional loss was highly correlated with high
or very low potassium levels in the cardioplegia (Figures 8A–C).
Nearly 40% of AL (0.1mMK+) and 25mMK+ alone hearts failed
to return HR, developed pressures or CO after 1 h arrest at 32–
33◦C. In 2009, Rudd and Dobson advanced the AL cardioplegic
concept as a new paradigm for orthotopic heart transplantation,
and showed that arrest and reanimation was versatile at both
cold (4◦C) and warmer (28–30◦C) temperatures compared with
Celsior solution (Rudd and Dobson, 2009). In 2011, Rudd and
Dobson further showed that the rat heart could be placed in
suspended animation with AL, insulin and melatonin for 8 h in
cold static storage (4◦C) and returned 80% of left ventricular
function compared to two FDA approved preservation solutions,
Custodiol-HTK and Celsior, that could barely return 10% left
ventricular function (Rudd and Dobson, 2011b). Further stud-
ies are underway to further improve ALM™ cardioplegia and
preservation solutions.
Reanimation with ALM: key to restoring a broken heart
The AL concept of voltage control and defending ionic and
metabolic balance may also be applicable for reperfusion follow-
ing heart surgery or organ storage. Canyon and Dobson showed
that pre-treatment (i.e., preconditioning) with intravenous low
dose AL infusion 5min prior and during 30min of regional
ischemia led to superior protection from acute ischemic damage
resulting in no death, no severe arrhythmias and a significant 38%
decrease in infarct size (Canyon and Dobson, 2004). In contrast,
fifty-eight percent (58%) of saline controls died from ventricular
fibrillation (Canyon and Dobson, 2004). In another study,
the adenosine A1 agonist 2-chloro-N6-cyclopentyladenosine
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FIGURE 8 | Effect of increasing extracellular potassium in AL
cardioplegia on return of cardiac output, time to first beat and stroke
volume after 1 and 2h arrest at 32–33◦C in the isolated working rat
heart [Adapted from Sloots and Dobson (2010)]. (A) Percentage
recovery of cardiac output in following 2h arrest at 32–33◦C. +AL (5.9mM
K+) p < 0.01 (One-Way analysis of variance) compared with AL (3, 10,
16mM K+) and 16mM K+ alone. ++AL (5.9mM K+) p < 0.01 (One-Way
analysis of variance) compared with AL (3mM K+); p < 0.05 (repeated
measures) compared with AL (3,16mM K+) and 16mM K+ alone. ∗AL
(10mM K+) p < 0.01 (repeated measures) compared with AL (3mM K+).
(B) Relationship between the time to first beat at reanimation after 1 or 2 h
arrest and the concentration of potassium in AL cardioplegia solution (5.9,
10, and 16mM K+). (C) Relationship between stroke volume and increasing
concentrations of potassium in AL cardioplegia solution (5.9, 10, and 16mM
K+) at 60min reperfusion after 1 and 2 h arrest.
(CCPA) was substituted for adenosine, and the CCPA-lidocaine
combination showed remarkable infarct size reduction of over
80%, which was equivalent to that of ischemic preconditioning
itself (Canyon and Dobson, 2005). In 2006, Canyon and Dobson
showed using 31P nuclear magnetic resonance (NMR) that the
protective effects of AL constant infusion therapy were expressed
as preservation of high-energy phosphates (ATP, PCr) in the
area-at-risk of the left ventricle, and this was explained by a
down-regulation of the myocardium during ischemia (Canyon
and Dobson, 2006). This in vivo study is consistent with the
energy-sparing properties shown in the cardioplegia studies.
That the ATP and PCr concentrations were maintained during
ischemia supports our hypothesis that AL pretreatment/ischemia
therapy may provide protection by ensuring better metabolic
and electrical matching in different heterogeneous regions of the
heart, and may be useful for off-pump surgery or angioplasty.
In 2011 Rudd and Dobson combined the polarizing AL
arrest and reperfusion strategy to cold preservation of the heart.
Rewarming the donor rat heart after 6 or 8 h cold static storage for
5min with a normokalemic, oxygenated, polarizing AL arrest solu-
tion resulted in significantly higher aortic flow, coronary flow, and
cardiac output compared with controls and other FDA-approved
solutions (Rudd and Dobson, 2011a,b). Interestingly, rewarm-
ing cold hyperkalemic Celsior hearts with polarizing AL solution
reduced stunning compared with the hyperkalemic “hot shot”
(Rudd and Dobson, 2011a). With this strategy Rudd and Dobson
added a fifth new approach to minimize myocardial damage dur-
ing rewarming and implantation of donor hearts, and possibly
other organs. These five strategies are (1) temperature control,
(2) hemodynamic control (unloaded nonworking mode), (3)
pressure control, (4) reperfusate control, and (5) membrane volt-
age control using normokalemic, polarizing strategies (Rudd and
Dobson, 2011a).
ALM™ CARDIOPLEGIA: FROM CONCEPT TO CLINICAL
TRIALS
THE VERONA TRIAL: FIRST PROSPECTIVE, RANDOMIZED TRIAL
The Verona trial was an important trial as it was the first ran-
domized prospective clinical trial using ALM™ (with insulin) in
microplegia compared to 4:1 Buckberg solution (Onorati et al.,
2012). Eighty adult patients were selected from a total of 878
and were emergency cases with unstable angina and required
CABG surgery only (not valve). Patients were randomized to
receive either standard 4:1 blood (“Buckberg”) cardioplegia or
all-blood cardioplegia (microplegia) enhanced with ALM and
insulin (Onorati et al., 2012). The authors found that ALM-
insulin significantly (1) reduced transmyocardial troponin-I and
lactate release, (2) improved post-operative cardiac function,
(3) increased the incidence of return of spontaneous rhythm at
declamping, (4) reduced the use of higher doses of inotropic
agents, (5) reduced blood transfusions and use of most blood
products, and (6) decreased the length of both ICU and total
hospital stay compared to the 4:1 Buckberg blood cardioplegia
formulation (Table 1). There was no mortality in either group,
and therefore mortality is not the only important end point
with impact. The authors note that further multi-center trials are
required, and it may be of interest to include a full cost saving
analysis since in their study the one full day less in the ICU in
the USA would represent a savings of $4000–10,000 per patient
(Rapoport et al., 2003), along with the 50% reduction in use of
blood products with direct and indirect costs ranging between
$522 and $1183 per unit of red cells (Shander et al., 2010). From a
safety perspective, blood transfusions are not “outcome neutral”
and may negatively impact on patient recovery in the ICU (Gong
et al., 2005).
ALM™ PROTECTION IN A 4× REDO PATIENT REQUIRING 7 h
CARDIOPLEGIC ARREST
ALM cardioplegia was used in a high risk case at Intermountain
Medical Center, Salt Lake City (O’Rullian et al., 2008). The
patient was a 71 year-old four-time redo male who was diag-
nosed with prosthetic valve endocarditis of both aortic and
mitral valves, and subsequently required a re-operative aortic and
mitral valve replacement. The patient was placed CPB and the
heart was arrested within 15 s using normothermic all-blood AL
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Table 1 | Prospective Randomized Human trial data comparing Microplegia ALM(I) with 4:1 Buckberg Solution.
ALM(I) Microplegia (n = 40) Buckberg (4:1) (n = 40) P-level Significance
MYOCARDIAL PROTECTION
• Troponin (during operation, 6,
12, and 48h
0.5–2.5 1.25–7.0 0.001  
• Lactate (same as above) 0.7–1.5 1.5–2.5 0.0001  
CARDIAC PERFORMANCE
• Cardiac Index (cardiac
output/m2)
3.9 2.75 0.0001  
• Systolic Function (cardiac
efficiency (CCE), pressure wave
profile (p/t), wall motion
score index (WMSI)
↑CCE↑p/t↑WMSI Lower Systolic Function <0.05  
• Diastolic Function (E-wave,
E/A,and Ea at TD)
↓E-wave↓Ea velocity↑E, ↑E/Aand ↑Ea Lower Diastolic Function <0.05  
• Return Spontaneous Rhythm at
Declamping (%)
78 28 0.001  
• Perioperative acute MI (%) 2.5 5.0 1.0 NS
• Low output syndrome (%) 5 12.5 0.432 NS
• Balloon support (IABP)(%) 5 10 0.675 NS
• Use of Inotropes (%) 57% 85%  
• Length of time inotropes (h) 31 51 0.041  
BLOOD TRANSFUSION
• % patients needing blood (pts) 25 58 0.001  
• Red Packed cells (U/pt) 0.3 1.3 0.001  
• Fresh Frozen plasma 0.2 1.3 0.001  
• Platelets (Units/pt) 0.02 1.3 0.149 NS
ICU AND HOSPITAL STAY
• ICU (H) 48 73 0.015  
• Total hospital (days) 7.4 9.4 0.002  
• Mortality No Mortality No Mortality NS
Data are post-operative with significance level on RHS column (Onorati et al., 2012). The Italian authors confusingly refer to trend when talking about significant
differences (P < 0.05). Actual p-values are included above. ALM(I) is adenosine, lidocaine and Mg2+, and Insulin.
microplegia (AL with 25mEq/L KCl, 16mMMgSO4). Arrest was
maintained with 7◦C near-continuous retrograde AL microple-
gia using 0–2mEq/L added potassium. After four cross-clamp
periods from bleeding and valve seating complications, the heart
was reanimated with a normokalemic blood “hot-shot” com-
prised of two liters of AL with magnesium but without KCl.
Ultimately, hemostasis was achieved and the patient was weaned
from CPB without requiring an intra-aortic balloon pump, on
a standard regimen of inotropic agents, and was extubated after
12 h. The patient was on CBP for 9 h and 50min, with a total
cross-clamp time of 7 h. The heart was perfused with a total of
72 liters all-blood AL microplegia. However, the total crystalloid
volume used for the additives and potassium was 250ml. Post-
operatively, there was no systemic hyperkalemia (5.1mmol/L)
no hemodilution (hematocrit 24%), and no remarkable edema.
This single case report shows how using AL at physiological
potassium levels may find utility in very high-risk patients with
prolonged bypass and cardioplegia volumes. Curiously, adeno-
sine is known to have a short-half life in blood in vitro (reported
to range from 4 to 10 seconds), however, this does not appear
to limits AL’s ability to arrest or protect the heart in the pedi-
atric or high-risk case study indicating protection in animal and
human studies may come from continuous activation of the
adenosine receptors together with voltage-dependent Na+ fast
channel modulation.
SAFETY OF AL CRYSTALLOID CARDIOPLEGIA FOR PEDIATRIC CARDIAC
SURGERY
Cardioprotection during pediatric surgery represents a major
unmet need. Jin and colleagues (Jin et al., 2008) conducted
a prospective, single-center, randomized clinical trial involving
134 pediatric patients with low-risk congenital heart disease. On
the day of surgery, surgeons and intensive care physicians were
blinded to three crystalloid cardioplegic formulations; high potas-
sium group (K+, 20mM), high potassium AL group (20mM
K+, 0.7mM A, 0.7mM L) and moderate potassium AL group
(10mM K+, 0.7mM A, 0.7mM L). Around 80% of patients
had ventricular septal defects (VSD) and 60% had concomitant
pulmonary hypertension. There were no significant differences
among the three groups in defect types, age, sex or body weight
or hemodynamics before CPB. The arrest protocol comprised a
single hypothermic (ice-cold) antegrade infusion of 20ml kg−1
crystalloid cardioplegia administered over a 2min period (100ml
per min for a total volume of ∼200ml). The cardioplegia was
aspirated by means of vigorous suction at the coronary sinus to
prevent distribution into the systemic circulation.
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There were no significant group differences in time to arrest,
cross-clamp time, cardiopulmonary bypass (CPB) time, peri-
operative hematocrit, fluid output at the end of the operation,
mechanical ventilation time, total mediastinal drainage, ICU
time (∼2.5 days) and post-operative hospital time (11–13 days).
However, there was a trend toward higher number days spent in
hospital and high potassium in the cardioplegia. The total post-
operative hospital time for the high K+ group was 12.7 ± 1.2
days, followed by high K+(AL) (11.8 ± 0.6 days) and the lowest
was in the moderate 10mM K+(AL) group (11.1 ± 1.4 days) (Jin
et al., 2008). Furthermore, there were significantly higher systolic
and pulse pressures following CPB in the 10mM K+(AL) group
compared with the non-AL 20mM K+ group, and again after
modified ultrafiltration. Similarly, serum Troponin I levels were
significantly lower in the moderate 10mM K+(AL) group com-
pared to both the non-AL 20mM K+ group and High K+(AL)
group in the first 12 h following cross-clamp removal. The 10mM
K+(AL) group had serum troponin levels that were 37, 48, 63,
and 62 of the values measured in the non-AL K+ group at 1, 3, 6,
and 12 h respectively. Jin et al., also reported a 30% lower use of
post-operative inotropes in the 10mM K+(AL) group compared
to non-AL 20mM K+ group (Jin et al., 2008). Unfortunately,
Jin et al. (2008) did not test AL with physiological potassium
concentrations (∼5mM K+). The authors concluded that AL in
hyperkalemic andmoderately hyperkalemic crystalloid cardiople-
gia was safe and effective, and that 10mM K+(AL) cardioplegia
formulation was associated with improved protective effects in
pediatric patients.
BEYOND CARDIOPLEGIA: ALM™ AS A BIOLOGICAL
RESPONSE MODIFIER IN TRAUMA, INFLAMMATION,
COAGULOPATHY, AND SEPSIS
Since the heart returns such vigorous activity with less need
for cardioversion and inotropic support following heart surgery,
at James Cook University we began to investigate the ability
of non-arresting concentrations of ALM to rescue and stabi-
lize the heart following severe blood loss and shock. The key
point is that ALM at high concentrations “arrests” the heart, and
at lower concentrations resuscitates the heart. In our first hem-
orrhagic shock study, we confirmed that colloids 6% and 10%
hetastarch or 6% dextran were problematic on cardiac stabil-
ity, hemodynamics and all led to increased mortality in the rat
model (Letson and Dobson, 2011a,b). In a second study, we
showed that ∼1ml/kg bolus (∼8 drops per 300 g rat) of 7.5%
NaCl/ALM (without colloids) solved this problem by rescuing the
heart and resuscitating MAP into a hypotensive range (Letson
and Dobson, 2011a,b), and further it fully corrected acute trau-
matic hypocoagulopathy (Letson et al., 2012b). In a third study,
we reported an unexpected 100% survival in the 7.5% NaCl ALM
group after 60% blood loss with higher MAP and few or no
arrhythmias compared with 7.5% NaCl alone, or any other treat-
ment groups (Letson and Dobson, 2011c). ALM also has the
advantage of displaying potent anti-inflammatory properties by
reducing the priming and activation of neutrophils (Shi et al.,
2012).
In 2012, Letson and colleagues successfully translated ALM ™
resuscitation from rat into the pig model of 75% blood loss
(Letson et al., 2012a). Small volume 4ml/kg 7.5% NaCl ALM
resuscitated MAP into the hypotensive region with a 2-fold
increase in stroke volume, a 34% fall in blood lactate and a 43%
higher O2 delivery. After the shed blood (∼2L) was returned
whole body O2 consumption fell, systemic vascular resistance
increased 30%, and urine output in the ALM group increased
threefold compared with 7.5% NaCl treatment (Letson et al.,
2012a). Importantly, small volume 7.5% NaCl (vehicle control)
was not optimal in rat or pig, which is consistent with the recent
randomized, multi-center trial that reported no significant bene-
fit of 250ml 7.5% NaCl, or 7.5% NaCl 6% Dextran-70 compared
to normal saline for early resuscitation of hemorrhagic shock
(Bulger, 2011). The cardiac rescue potential of small volume
7.5% NaCl ALM was further demonstrated by Grandfeldt and
colleagues who showed that a 20ml bolus of 7.5% NaCl ALM
(0.5ml/kg) significantly reduced fluid requirement by 40% to
reach a target MAP of 50mmHg in pig model following 75%
blood loss (Granfeldt et al., 2012), and a 10ml bolus injec-
tion of 0.9% NaCl AL (no Mg2+) with return of shed blood
led to a significant 27% drop in whole body O2 consump-
tion and improved cardiac and renal function (Granfeldt et al.,
2012). Lastly, pilot rat and sepsis studies show that an IV infu-
sion of ALM ™ improves cardiac function, reduces neutrophil
activation and TnF alpha, and reduces whole body O2 con-
sumption. Further work is required to test if these strategies
are safe and efficacious in the preshospital civilian environ-
ment or on the battlefield where few saline based or colloid-
based resuscitation fluids drugs currently work (Blackbourne
et al., 2010). However, since cardiac surgery involves trauma,
inflammation, and coagulopathy, it is possible that the ALM
™ polarized concept may be therapeutic and provide whole
body protection for the patient as was indicated from aspects
of the Verona trial. A future goal will be to examine the
effect of ALM ™ infusion to protect the brain during circula-
tory arrest for aortic reconstruction surgery in pediatrics and
adults.
CONCLUDING REMARKS
Despite groundbreaking advances in global health care, cardiac
surgeons, anesthetists and perfusionists are confronted with a
new older and sicker patient with an increasing risk profile. The
new patient may require complex redo surgery or other emer-
gency procedures from failed angioplasties, cardiogenic shock,
or congenital defects. Depolarizing potassium cardioplegia may
not provide optimal perioperative protection for today’s adult or
pediatric patient. New innovations are required and the ALM
™ concept with other additions may offer a new normokalemic
polarizing strategy for heart and whole body protection. While
the outcomes from early human trials appear promising, further
prospective, randomized multi-center clinical trials are required.
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